These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9533534

  • 41. Serum hepatocyte growth factor before and after resection for hepatocellular carcinoma.
    Hu RH, Lee PH, Yu SC, Sheu JC, Lai MY.
    Hepatogastroenterology; 1999; 46(27):1842-7. PubMed ID: 10430357
    [Abstract] [Full Text] [Related]

  • 42. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma.
    Vejchapipat P, Tangkijvanich P, Theamboonlers A, Chongsrisawat V, Chittmittrapap S, Poovorawan Y.
    J Gastroenterol; 2004 Dec; 39(12):1182-8. PubMed ID: 15622483
    [Abstract] [Full Text] [Related]

  • 43. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
    Greenberg R, Barnea Y, Schneebaum S, Kashtan H, Kaplan O, Skornik Y.
    Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156
    [Abstract] [Full Text] [Related]

  • 44. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I, Dolled-Filhart M, D'Aquila TG, Camp RL, Rimm DL.
    Cancer; 2003 Apr 15; 97(8):1841-8. PubMed ID: 12673709
    [Abstract] [Full Text] [Related]

  • 45. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec 15; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [A strong predictor of breast cancer--hepatocyte growth factor (HGF)].
    Sakai K, Yamashita J, Ogawa M.
    Gan To Kagaku Ryoho; 1995 Apr 15; 22 Suppl 1():71-4. PubMed ID: 7747995
    [Abstract] [Full Text] [Related]

  • 48. Serum evaluation of basic FGF in breast cancer patients.
    Sliutz G, Tempfer C, Obermair A, Dadak C, Kainz C.
    Anticancer Res; 1995 Apr 15; 15(6B):2675-7. PubMed ID: 8669845
    [Abstract] [Full Text] [Related]

  • 49. Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer.
    Sheen-Chen SM, Eng HL, Sheen CW, Cheng YF, Chou FF, Chen WJ.
    Anticancer Res; 1997 Apr 15; 17(4A):2823-6. PubMed ID: 9252723
    [Abstract] [Full Text] [Related]

  • 50. Clinical value of plasma hepatocyte growth factor measurement for the diagnosis of periampullary cancer and prognosis after pancreaticoduodenectomy.
    Barakat O, Rodriguez GC, Raijman I, Allison PM, Nieto J, Ozaki CF, Wood RP, Engler DA.
    J Surg Oncol; 2010 Dec 01; 102(7):816-20. PubMed ID: 20812348
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone- refractory prostate cancer: results from cancer and leukemia group B 150005/9480.
    Humphrey PA, Halabi S, Picus J, Sanford B, Vogelzang NJ, Small EJ, Kantoff PW.
    Clin Genitourin Cancer; 2006 Mar 01; 4(4):269-74. PubMed ID: 16729910
    [Abstract] [Full Text] [Related]

  • 53. Expression of hepatocyte growth factor in breast cancer and its effect on prognosis and sensitivity to chemotherapy.
    Yang H, Zhang C, Cui S.
    Mol Med Rep; 2015 Feb 01; 11(2):1037-42. PubMed ID: 25351134
    [Abstract] [Full Text] [Related]

  • 54. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific pro-cathepsin D immunoassay.
    Brouillet JP, Dufour F, Lemamy G, Garcia M, Schlup N, Grenier J, Mani JC, Rochefort H.
    Cancer; 1997 Jun 01; 79(11):2132-6. PubMed ID: 9179059
    [Abstract] [Full Text] [Related]

  • 55. [Contact thermography as a prognostic indicator of breast cancer].
    Ikeda T, Abe O, Enomoto K, Kikuchi K, Fujiwara K.
    Gan To Kagaku Ryoho; 1989 May 01; 16(5):2103-8. PubMed ID: 2658842
    [Abstract] [Full Text] [Related]

  • 56. [Clinical studies on serum glutathione S-transferase level in human breast cancer patients].
    Liu TX, Song ST, Li CH.
    Zhonghua Zhong Liu Za Zhi; 1994 Nov 01; 16(6):411-4. PubMed ID: 7720493
    [Abstract] [Full Text] [Related]

  • 57. Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease.
    Matsuno M, Shiota G, Umeki K, Kawasaki H, Kojo H, Miura K.
    Res Commun Mol Pathol Pharmacol; 1997 Jul 01; 97(1):25-37. PubMed ID: 9507565
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Serum level of angiogenin in breast cancer.
    Sheen-Chen SM, Eng HL, Chen WJ, Chou FF, Chen HS.
    Anticancer Res; 2000 Jul 01; 20(6C):4769-71. PubMed ID: 11205216
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.